Literature DB >> 11342574

Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter.

M S Lipkowitz1, E Leal-Pinto, J Z Rappoport, V Najfeld, R G Abramson.   

Abstract

Elevated serum levels of uric acid have been associated with an increased risk for gout, hypertension, cardiovascular disease, and renal failure. The molecular mechanisms for the diminished excretion of urate in these disorders, however, remain poorly understood. Human galectin 9, which is highly homologous to the rat urate transporter rUAT, has been reported to be a secreted or cytosolic protein. We provide data that galectin 9 is hUAT, the first identified human urate transporter. hUAT is a highly selective urate ion channel when inserted in lipid bilayers. When expressed in renal epithelial cells it is an integral plasma membrane protein with at least two transmembrane domains. The gene for hUAT consists of 11 exons and is mapped to chromosome 17; a highly homologous gene, hUAT2, maps to a nearby region of chromosome 17 and is also likely to be a urate transporter. hUAT is expressed in a wide variety of tissues and is present in at least three isoforms; hUAT2 is less widely expressed at severalfold lower levels than hUAT. Further knowledge about the functions of hUAT, its isoforms, and hUAT2, as well as mutational analysis of hUAT1 and hUAT2 in individuals or families with hyperuricemia, should significantly improve our understanding of the molecular mechanisms of urate homeostasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342574      PMCID: PMC209284          DOI: 10.1172/JCI12471

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

Review 1.  Secretion of the galectin family of mammalian carbohydrate-binding proteins.

Authors:  R C Hughes
Journal:  Biochim Biophys Acta       Date:  1999-12-06

2.  Is raised serum uric acid a cause of cardiovascular disease or death?

Authors:  A Dobson
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

3.  Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout.

Authors:  A B GUTMAN; T F YU
Journal:  Am J Med       Date:  1957-10       Impact factor: 4.965

4.  Single-step purification/solubilization of recombinant proteins: application to surfactant protein B.

Authors:  A Holzinger; K S Phillips; T E Weaver
Journal:  Biotechniques       Date:  1996-05       Impact factor: 1.993

5.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

6.  Serum uric acid and related factors in 500 hospitalized subjects.

Authors:  F Saggiani; S Pilati; G Targher; P Branzi; M Muggeo; E Bonora
Journal:  Metabolism       Date:  1996-12       Impact factor: 8.694

7.  Galectins: a family of animal beta-galactoside-binding lectins.

Authors:  S H Barondes; V Castronovo; D N Cooper; R D Cummings; K Drickamer; T Feizi; M A Gitt; J Hirabayashi; C Hughes; K Kasai
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

8.  Serum uric acid and cardiovascular events in successfully treated hypertensive patients.

Authors:  M H Alderman; H Cohen; S Madhavan; S Kivlighn
Journal:  Hypertension       Date:  1999-07       Impact factor: 10.190

Review 9.  Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.

Authors:  R J Johnson; S D Kivlighn; Y G Kim; S Suga; A B Fogo
Journal:  Am J Kidney Dis       Date:  1999-02       Impact factor: 8.860

10.  Newly discovered familial juvenile gouty nephropathy in a Japanese family.

Authors:  A Saeki; T Hosoya; H Okabe; M Saji; A Tabe; K Ichida; K Itoh; K Joh; O Sakai
Journal:  Nephron       Date:  1995       Impact factor: 2.847

View more
  17 in total

Review 1.  Galectin genes: regulation of expression.

Authors:  Lorenzo Chiariotti; Paola Salvatore; Rodolfo Frunzio; Carmelo B Bruni
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

2.  Galectin multimerization and lattice formation are regulated by linker region structure.

Authors:  Lesley A Earl; Shuguang Bi; Linda G Baum
Journal:  Glycobiology       Date:  2010-09-23       Impact factor: 4.313

Review 3.  Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.

Authors:  Atsushi Enomoto; Hitoshi Endou
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

Review 4.  Update on gout: pathophysiology and potential treatments.

Authors:  Aryeh M Abeles; Jean Y Park; Michael H Pillinger; Bruce N Cronstein
Journal:  Curr Pain Headache Rep       Date:  2007-12

5.  Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.

Authors:  Michael R Wiederkehr; Orson W Moe
Journal:  Clin Rev Bone Miner Metab       Date:  2011-12

6.  G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome.

Authors:  Won Cheoul Jang; Youn Hyoung Nam; Young Chang Ahn; Su Min Park; Il Kyu Yoon; Jung-Yoon Choe; Sung-Hoon Park; Minyoung Her; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2011-05-05       Impact factor: 2.631

7.  The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia.

Authors:  Fusako Komoda; Takashi Sekine; Jun Inatomi; Atsushi Enomoto; Hitoshi Endou; Toshiyuki Ota; Takeshi Matsuyama; Tsutomu Ogata; Masahiro Ikeda; Midori Awazu; Koji Muroya; Isamu Kamimaki; Takashi Igarashi
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

Review 8.  Hyperuricemia and gout.

Authors:  Frédéric Lioté
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

9.  Uric Acid nephrolithiasis: recent progress and future directions.

Authors:  Tin C Ngo; Dean G Assimos
Journal:  Rev Urol       Date:  2007

Review 10.  Galectin 9 is the sugar-regulated urate transporter/channel UAT.

Authors:  Michael S Lipkowitz; Edgar Leal-Pinto; B Eleazar Cohen; Ruth G Abramson
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.